Related Experiment Video
Updated: Jan 25, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs
Misako Yajima1, Mamiko Miyata2, Kazufumi Ikuta3
1Division of Microbiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai 983-8536, Japan. yajima@tohoku-mpu.ac.jp.
Abstract:
Epstein-Barr virus (EBV) genomes, particularly their latent genes, are heterogeneous among strains. The heterogeneity of EBV-encoded latent membrane protein 1 (LMP1) raises the question of whether there are functional differences between LMP1 expressed by cancer-associated EBV and that by non-cancerous strains. Here, we used bacterial artificial chromosome (BAC)-cloned EBV genomes retaining all virally encoded microRNA (miRNA) genes to investigate the functions of cancer-derived LMP1 in the context of the EBV genome. HEK293 cells were stably transfected with EBV-BAC clone DNAs encoding either nasopharyngeal carcinoma (NPC)-derived CAO-LMP1 (LMP1CAO) or LMP1 from a prototype B95-8 strain of EBV (LMP1B95-8). When an EBV-BAC clone DNA encoding LMP1CAO was stably transfected into HEK293 cells, it generated many more stable transformants than the control clone encoding LMP1B95-8. Furthermore, stably transfected HEK293 cells exhibited highly efficient production of progeny virus. Importantly, deletion of the clustered viral miRNA genes compromised the ability to produce progeny viruses. These results indicate that cancer-derived LMP1 and viral miRNAs together are necessary for efficient production of progeny virus, and that the resulting increase in efficiency contributes to EBV-mediated epithelial carcinogenesis.
Insights
Cancer-derived Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) and viral microRNAs (miRNAs) enhance progeny virus production. This synergy contributes to EBV-driven epithelial cancers.
Area of Science:
- Virology
- Molecular Biology
- Cancer Research
Background:
- Epstein-Barr virus (EBV) genomes exhibit strain heterogeneity, particularly in latent genes.
- The functional differences of EBV-encoded latent membrane protein 1 (LMP1) between cancer-associated and non-cancerous strains remain unclear.
Purpose of the Study:
- To investigate the functional differences of cancer-derived LMP1 within the context of the EBV genome.
- To elucidate the roles of LMP1 and viral microRNAs (miRNAs) in EBV replication and epithelial carcinogenesis.
Main Methods:
- Utilized bacterial artificial chromosome (BAC)-cloned EBV genomes containing all viral miRNA genes.
- Stably transfected HEK293 cells with EBV-BAC clones encoding either nasopharyngeal carcinoma (NPC)-derived CAO-LMP1 (LMP1CAO) or prototype B95-8 strain LMP1 (LMP1B95-8).
- Assessed the generation of stable transformants and progeny virus production, including experiments with deleted viral miRNA genes.
Main Results:
- EBV-BAC DNA encoding LMP1CAO generated significantly more stable transformants than LMP1B95-8 in HEK293 cells.
- Stably transfected cells showed highly efficient production of progeny virus.
- Deletion of viral miRNA genes impaired progeny virus production, indicating a synergistic role with LMP1.
Conclusions:
- Cancer-derived LMP1 and viral miRNAs are crucial for efficient EBV progeny virus production.
- This enhanced viral production contributes to EBV-mediated epithelial carcinogenesis.
- Strain-specific variations in LMP1 and miRNAs play a significant role in EBV pathogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
What are Viruses?
Production Efficiency
Viral Recombination
Viral Structure

